Anavex Life Sciences Corp (AVXL)

[Pineapple1]

10% gain on a grant is way too much. Hmm let's make some assumptions shall we. If our product is able to become the standard of care for Alzheimer, say revenue stream of 5b/Yr and the normal market capitalization of a publicly traded company is 5 times revenue that would imply a 25b MC. Retts is a much smaller patient population, but continued validation by multiple organizations independent of each other, leads one to believe that evidence is mounting for much larger gains than 10%. Something will light the fuse of value, don't know what, or when but I have a stronger feeling that it will happen.